Serra Ventures

Serra Ventures is a venture capital firm based in Champaign, Illinois, that invests in technology companies across the United States and select international locations. The firm concentrates on early-stage and growth opportunities in information technology, deep technology, instrumentation, software as a service, devices, B2B, and agricultural technologies, with a focus on the Midwest and West Coast regions. Serra Ventures supports portfolio companies through strategic guidance, networks, and resources to help scale technology-enabled businesses.

Dennis Beard

Managing Partner

Drew Beard

Associate

Steve Beck

Managing Partner

Timothy Hoerr

Managing Partner

Karin O'Connor

Venture Partner

Robert Schultz

Managing Partner

Past deals in Missouri

Ryvit

Seed Round in 2019
Ryvit develops integration software tailored for the construction industry. Its platform facilitates seamless data flow between various premise-based and cloud software applications, including enterprise resource products, CRM, e-commerce platforms, social apps, and industry-specific systems. Headquartered in Saint Louis, Missouri, Ryvit empowers businesses to automate workflows and optimize application usage without straining development resources.

Kypha

Venture Round in 2017
Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.

OPER

Venture Round in 2017
Founded in 2015, OPER is a St. Louis-based company offering a mobile platform for restaurant payments and rewards. It enables customers to order food, pay directly through the app, and earn rewards, while restaurants benefit from streamlined operations, enhanced customer experiences, and data-driven insights.

Adarza BioSystems

Series C in 2017
Adarza BioSystems is an early-stage medical diagnostics company based in St. Louis, Missouri, that specializes in developing a rapid and label-free biological assay platform for clinical and point-of-care samples. Founded in 2008, the company utilizes its innovative arrayed imaging reflectometry technology to enable the simultaneous detection of hundreds of analytes from a single drop of fluid. This platform allows healthcare professionals to conduct sophisticated tests in a matter of minutes, ensuring high sensitivity and specificity in the detection of multiplexed proteins. Adarza BioSystems aims to enhance diagnostic capabilities, improving patient outcomes through quicker and more accurate testing.

Kypha

Venture Round in 2017
Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.

Label Insight

Venture Round in 2016
Label Insight, Inc. is a St. Louis-based company that specializes in a cloud-based product data engine designed to help brands and retailers manage and understand their product data. Founded in 2004, the company collects, aggregates, and analyzes a wide range of information from product packaging, including descriptions, nutrients, ingredients, allergens, marketing claims, and certifications. This comprehensive data allows CPG brands, retailers, and food industry stakeholders to compare and analyze products across various categories, such as food and beverage, apparel, personal care, and electronics. By transforming basic product information into detailed attributes, Label Insight empowers companies to unlock growth opportunities and enhances consumer decision-making by providing greater transparency regarding product contents. The company also has an operational presence in Canada and a secondary office in Chicago, Illinois.

OPER

Seed Round in 2016
Founded in 2015, OPER is a St. Louis-based company offering a mobile platform for restaurant payments and rewards. It enables customers to order food, pay directly through the app, and earn rewards, while restaurants benefit from streamlined operations, enhanced customer experiences, and data-driven insights.

Kypha

Venture Round in 2016
Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.

Adarza BioSystems

Series B in 2016
Adarza BioSystems is an early-stage medical diagnostics company based in St. Louis, Missouri, that specializes in developing a rapid and label-free biological assay platform for clinical and point-of-care samples. Founded in 2008, the company utilizes its innovative arrayed imaging reflectometry technology to enable the simultaneous detection of hundreds of analytes from a single drop of fluid. This platform allows healthcare professionals to conduct sophisticated tests in a matter of minutes, ensuring high sensitivity and specificity in the detection of multiplexed proteins. Adarza BioSystems aims to enhance diagnostic capabilities, improving patient outcomes through quicker and more accurate testing.

Label Insight

Series B in 2016
Label Insight, Inc. is a St. Louis-based company that specializes in a cloud-based product data engine designed to help brands and retailers manage and understand their product data. Founded in 2004, the company collects, aggregates, and analyzes a wide range of information from product packaging, including descriptions, nutrients, ingredients, allergens, marketing claims, and certifications. This comprehensive data allows CPG brands, retailers, and food industry stakeholders to compare and analyze products across various categories, such as food and beverage, apparel, personal care, and electronics. By transforming basic product information into detailed attributes, Label Insight empowers companies to unlock growth opportunities and enhances consumer decision-making by providing greater transparency regarding product contents. The company also has an operational presence in Canada and a secondary office in Chicago, Illinois.

Kypha

Debt Financing in 2015
Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.

Label Insight

Venture Round in 2015
Label Insight, Inc. is a St. Louis-based company that specializes in a cloud-based product data engine designed to help brands and retailers manage and understand their product data. Founded in 2004, the company collects, aggregates, and analyzes a wide range of information from product packaging, including descriptions, nutrients, ingredients, allergens, marketing claims, and certifications. This comprehensive data allows CPG brands, retailers, and food industry stakeholders to compare and analyze products across various categories, such as food and beverage, apparel, personal care, and electronics. By transforming basic product information into detailed attributes, Label Insight empowers companies to unlock growth opportunities and enhances consumer decision-making by providing greater transparency regarding product contents. The company also has an operational presence in Canada and a secondary office in Chicago, Illinois.

Label Insight

Convertible Note in 2015
Label Insight, Inc. is a St. Louis-based company that specializes in a cloud-based product data engine designed to help brands and retailers manage and understand their product data. Founded in 2004, the company collects, aggregates, and analyzes a wide range of information from product packaging, including descriptions, nutrients, ingredients, allergens, marketing claims, and certifications. This comprehensive data allows CPG brands, retailers, and food industry stakeholders to compare and analyze products across various categories, such as food and beverage, apparel, personal care, and electronics. By transforming basic product information into detailed attributes, Label Insight empowers companies to unlock growth opportunities and enhances consumer decision-making by providing greater transparency regarding product contents. The company also has an operational presence in Canada and a secondary office in Chicago, Illinois.

Kypha

Convertible Note in 2015
Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.

Tunespeak

Series A in 2015
Founded in 2011 and headquartered in St. Louis, Missouri, Tunespeak operates a musician-to-fan loyalty platform. Its platform enables users to earn points by engaging with music content such as listening to songs, watching videos, browsing photos, and sharing with friends.

Label Insight

Series A in 2014
Label Insight, Inc. is a St. Louis-based company that specializes in a cloud-based product data engine designed to help brands and retailers manage and understand their product data. Founded in 2004, the company collects, aggregates, and analyzes a wide range of information from product packaging, including descriptions, nutrients, ingredients, allergens, marketing claims, and certifications. This comprehensive data allows CPG brands, retailers, and food industry stakeholders to compare and analyze products across various categories, such as food and beverage, apparel, personal care, and electronics. By transforming basic product information into detailed attributes, Label Insight empowers companies to unlock growth opportunities and enhances consumer decision-making by providing greater transparency regarding product contents. The company also has an operational presence in Canada and a secondary office in Chicago, Illinois.

Kypha

Venture Round in 2014
Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.

Label Insight

Series A in 2014
Label Insight, Inc. is a St. Louis-based company that specializes in a cloud-based product data engine designed to help brands and retailers manage and understand their product data. Founded in 2004, the company collects, aggregates, and analyzes a wide range of information from product packaging, including descriptions, nutrients, ingredients, allergens, marketing claims, and certifications. This comprehensive data allows CPG brands, retailers, and food industry stakeholders to compare and analyze products across various categories, such as food and beverage, apparel, personal care, and electronics. By transforming basic product information into detailed attributes, Label Insight empowers companies to unlock growth opportunities and enhances consumer decision-making by providing greater transparency regarding product contents. The company also has an operational presence in Canada and a secondary office in Chicago, Illinois.

Kypha

Venture Round in 2014
Kypha Inc. is a life sciences company focused on the discovery, development, and commercialization of in-vitro diagnostic biomarker tests targeting inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Through its innovative platform, Kypha provides rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. The company's approach facilitates testing across diverse settings, from home health care to clinical laboratories, ultimately aiming to improve patient outcomes by optimizing treatment strategies based on real-time immune insights. Since its incorporation in 2009, Kypha has attracted significant funding and built a strong network of scientific and clinical expertise to support its mission.

Adarza BioSystems

Series A in 2014
Adarza BioSystems is an early-stage medical diagnostics company based in St. Louis, Missouri, that specializes in developing a rapid and label-free biological assay platform for clinical and point-of-care samples. Founded in 2008, the company utilizes its innovative arrayed imaging reflectometry technology to enable the simultaneous detection of hundreds of analytes from a single drop of fluid. This platform allows healthcare professionals to conduct sophisticated tests in a matter of minutes, ensuring high sensitivity and specificity in the detection of multiplexed proteins. Adarza BioSystems aims to enhance diagnostic capabilities, improving patient outcomes through quicker and more accurate testing.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.